Neuberger Berman Group LLC Decibel Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.41 - $4.81 $103,964 - $207,498	43,139 Added 275.45%	58,800 $226,000
Q1 2023 May 12, 2023	SELL	$2.08 - $4.79 $1,248 - $2,874	-600 Reduced 3.69%	15,661 $47,000
Q4 2022 Feb 13, 2023	SELL	$1.86 - $3.54 $97,350 - $185,280	-52,339 Reduced 76.3%	16,261 $33,000
Q3 2022 Nov 15, 2022	SELL	$3.82 - $5.61 $1,528 - $2,244	-400 Reduced 0.58%	68,600 $237,000
Q2 2022 Aug 15, 2022	BUY	$1.85 - $4.21 $11,423 - $25,996	6,175 Added 9.83%	69,000 $290,000
Q1 2022 May 13, 2022	BUY	$2.83 - $5.03 $9,211 - $16,372	3,255 Added 5.46%	62,825 $191,000
Q4 2021 Feb 11, 2022	BUY	$4.57 - $8.58 $73,279 - $137,580	16,035 Added 36.83%	59,570 $277,000
Q3 2021 Nov 12, 2021	BUY	$6.6 - $9.04 $1,221 - $1,672	185 Added 0.43%	43,535 $336,000
Q2 2021 Aug 13, 2021	BUY	$6.39 - $11.51 $98,086 - $176,678	15,350 Added 54.82%	43,350 $373,000
Q1 2021 May 13, 2021	BUY	$10.56 - $19.9 $295,680 - $557,200	28,000 New	28,000 $318,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.